基本資料
種類: ETF
費用比率%: 0.60
資產淨值: 32.73
成立日期: 11/12/2017
 
分析
市值分佈:
42.31%
大市值
2.51%
中市值
0.81%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 01/08/2026 05:19) 總持有投資項目: 151  
0%
 
100%
     10大 (16.92%)
代號 名稱 佔比% 持有日期
GILDGilead Sciences0.2128/07/2026
ACADACADIA Pharmaceuticals0.2029/07/2026
FASTFastenal Co0.2028/07/2026
CPTCamden Property Trust0.1928/07/2026
UDRUDR0.1928/07/2026
VCYTVeracyte0.1930/06/2026
ALNYAlnylam Pharmaceuticals0.1929/07/2026
ROKRockwell Automation0.1928/07/2026
WABWabtec0.1829/07/2026
BCRXBioCryst Pharmaceuticals0.1828/07/2026
BEAMBeam Therapeutics0.1728/07/2026
MLYSMineralys Therapeutics0.1730/06/2026
FRTFederal Realty Investment Trust0.1628/07/2026
IDYAIDEAYA Biosciences0.1628/07/2026
ARQTArcutis Biotherapeutics0.1628/07/2026
AXONAxon Enterprise0.1628/07/2026
NVAXNovavax0.1530/06/2026
CLDXCelldex Therapeutics0.1529/07/2026
TNGXTango Therapeutics0.1429/07/2026
QCOMQUALCOMM0.1429/07/2026
  1    2    3   4    5    6    7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.